Is Apo CIII the new cardiovascular target? An analysis of its current clinical and dietetic therapies Nutrition, Metabolism and Cardiovascular Diseases Metabolic fate of very low density lipoproteins (VLDL) and production of low density lipoproteins (LDL). (A, apolipoprotein A; B 100, apolipoprotein B 100; C, apolipoprotein C; C, cholesterol and cholesteryl ester; E, apolipoprotein E; HDL, ApoCIII: A multifaceted protein in cardiometabolic disease Metabolism Clinical and Experimental The known unknowns of apolipoprotein glycosylation in health and disease: iScience Emerging evidences for the opposite role of apolipoprotein C3 and apolipoprotein A5 in lipid metabolism and coronary artery disease Lipids in Health and Disease Springer Nature Link Lipoprotein Metabolism and Alterations Induced by Insulin Resistance and Diabetes Oncohema Key